84 related articles for article (PubMed ID: 25308264)
1. Detection of p53 protein transcriptional activity by chromatin immunoprecipitation.
Yang-Hartwich Y; Romanoff E; Bingham J; Alvero AB; Mor G
Methods Mol Biol; 2015; 1219():87-93. PubMed ID: 25308264
[TBL] [Abstract][Full Text] [Related]
2. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
[TBL] [Abstract][Full Text] [Related]
3. Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines.
Shaked H; Shiff I; Kott-Gutkowski M; Siegfried Z; Haupt Y; Simon I
Cancer Res; 2008 Dec; 68(23):9671-7. PubMed ID: 19047144
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.
Okoshi R; Ando K; Suenaga Y; Sang M; Kubo N; Kizaki H; Nakagawara A; Ozaki T
Genes Cells; 2009 Dec; 14(12):1429-40. PubMed ID: 19930465
[TBL] [Abstract][Full Text] [Related]
5. ChIP (chromatin immunoprecipitation) analysis demonstrates co-ordinated binding of two transcription factors to the promoter of the p53 tumour-suppressor gene.
Polson A; Takahashi P; Reisman D
Cell Biol Int; 2010 Sep; 34(9):883-91. PubMed ID: 20446924
[TBL] [Abstract][Full Text] [Related]
6. ChIP for identification of p53 responsive DNA promoters.
Liao JM; Lu H
Methods Mol Biol; 2013; 962():201-10. PubMed ID: 23150449
[TBL] [Abstract][Full Text] [Related]
7. AP2alpha alters the transcriptional activity and stability of p53.
Stabach PR; Thiyagarajan MM; Woodfield GW; Weigel RJ
Oncogene; 2006 Apr; 25(15):2148-59. PubMed ID: 16288208
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary study of p53 gene promoter binding site of activator protein-1 in A549 cell lines by chromatin immunoprecipitation].
Shen F; Li ZT; Wu YM; Wu WD
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Aug; 26(8):453-6. PubMed ID: 19358752
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-beta precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress.
Tang X; Milyavsky M; Goldfinger N; Rotter V
Oncogene; 2007 Nov; 26(52):7302-12. PubMed ID: 17533371
[TBL] [Abstract][Full Text] [Related]
10. Mitofusin-2 is a novel direct target of p53.
Wang W; Cheng X; Lu J; Wei J; Fu G; Zhu F; Jia C; Zhou L; Xie H; Zheng S
Biochem Biophys Res Commun; 2010 Oct; 400(4):587-92. PubMed ID: 20804729
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the RNA helicase p68 (Ddx5) as a transcriptional regulator.
Nicol SM; Fuller-Pace FV
Methods Mol Biol; 2010; 587():265-79. PubMed ID: 20225156
[TBL] [Abstract][Full Text] [Related]
12. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
[TBL] [Abstract][Full Text] [Related]
13. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
14. LMO3 interacts with p53 and inhibits its transcriptional activity.
Larsen S; Yokochi T; Isogai E; Nakamura Y; Ozaki T; Nakagawara A
Biochem Biophys Res Commun; 2010 Feb; 392(3):252-7. PubMed ID: 19995558
[TBL] [Abstract][Full Text] [Related]
15. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
16. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
17. Hepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53.
Weizer-Stern O; Adamsky K; Margalit O; Ashur-Fabian O; Givol D; Amariglio N; Rechavi G
Br J Haematol; 2007 Jul; 138(2):253-62. PubMed ID: 17593032
[TBL] [Abstract][Full Text] [Related]
18. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
[TBL] [Abstract][Full Text] [Related]
19. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter.
Liu H; Hew HC; Lu ZG; Yamaguchi T; Miki Y; Yoshida K
Biochem J; 2009 Aug; 422(3):543-51. PubMed ID: 19558368
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional down-regulation of Bcl-2 by vinorelbine: identification of a novel binding site of p53 on Bcl-2 promoter.
Bourgarel-Rey V; Savry A; Hua G; Carré M; Bressin C; Chacon C; Imbert J; Braguer D; Barra Y
Biochem Pharmacol; 2009 Nov; 78(9):1148-56. PubMed ID: 19555669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
